British Columbia introduced the pneumococcal polysaccharide 23-valent (PPV23) vaccine in 1996 for bone marrow transplant recipients and asplenics. Over the next 2 years, the program expanded to residents of long-term care and adults 65 years and older, implemented in the year one turns 65.